386 related articles for article (PubMed ID: 26846932)
1. Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice.
Li M; Zhang X; Zhao F; Luo Y; Kong L; Yu J
Radiat Oncol; 2016 Feb; 11():18. PubMed ID: 26846932
[TBL] [Abstract][Full Text] [Related]
2. Patterns of failure after involved field radiotherapy for locally advanced esophageal squamous cell carcinoma.
Li DJ; Li HW; He B; Wang GM; Cai HF; Duan SM; Liu JJ; Zhang YJ; Cui Z; Jiang H
J BUON; 2016; 21(5):1268-1273. PubMed ID: 27837632
[TBL] [Abstract][Full Text] [Related]
3. Involved-field radiotherapy (IFRT) versus elective nodal irradiation (ENI) in combination with concurrent chemotherapy for 239 esophageal cancers: a single institutional retrospective study.
Yamashita H; Takenaka R; Omori M; Imae T; Okuma K; Ohtomo K; Nakagawa K
Radiat Oncol; 2015 Aug; 10():171. PubMed ID: 26269033
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional conformal radiation therapy for esophageal squamous cell carcinoma: is elective nodal irradiation necessary?
Zhao KL; Ma JB; Liu G; Wu KL; Shi XH; Jiang GL
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):446-51. PubMed ID: 20004527
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional conformal radiation for esophageal squamous cell carcinoma with involved-field irradiation may deliver considerable doses of incidental nodal irradiation.
Ji K; Zhao L; Yang C; Meng M; Wang P
Radiat Oncol; 2012 Nov; 7():200. PubMed ID: 23186308
[TBL] [Abstract][Full Text] [Related]
6. Effect of bilateral supraclavicular postoperative radiotherapy in middle and lower thoracic esophageal carcinoma.
Ren Y; Su C; Zhou Y; Zhao X; Yang CL; Liu YY
World J Gastroenterol; 2014 Dec; 20(47):17970-5. PubMed ID: 25548496
[TBL] [Abstract][Full Text] [Related]
7. Involved-field irradiation concurrently combined with nedaplatin/5-fluorouracil for inoperable esophageal cancer on basis of (18)FDG-PET scans: a phase II study.
Yamashita H; Omori M; Takenaka R; Okuma K; Kobayashi R; Ohtomo K; Nakagawa K
Radiother Oncol; 2014 Nov; 113(2):182-7. PubMed ID: 25466372
[TBL] [Abstract][Full Text] [Related]
8. Involved-Field Irradiation in Definitive Chemoradiotherapy for Locoregional Esophageal Squamous Cell Carcinoma: Results From the ESO-Shanghai 1 Trial.
Zhu H; Rivin Del Campo E; Ye J; Simone CB; Zhu Z; Zhao W; Amini A; Zhou J; Wu C; Tang H; Fan M; Li L; Lin Q; Xia Y; Li Y; Li J; Mo M; Jia H; Lu S; Wang J; Nie Y; Chen J; Wu S; Hamaji M; Haque W; Jeong BK; Shridhar R; Zhang Z; Chen Y; Zhao K
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1396-1406. PubMed ID: 33677048
[TBL] [Abstract][Full Text] [Related]
9. [Radiochemotherapy for esophageal cancer: which nodes should be irradiated?].
Créhange G; Quivrin M; Vulquin N; Serre AA; Maingon P
Cancer Radiother; 2014 Oct; 18(5-6):577-82. PubMed ID: 25201634
[TBL] [Abstract][Full Text] [Related]
10. Comparison of elective nodal irradiation and involved-field irradiation in esophageal squamous cell carcinoma: a meta-analysis.
Cheng YJ; Jing SW; Zhu LL; Wang J; Wang L; Liu Q; Yang CR; Wang Y; Cao F; Jiao WP; Wu YJ
J Radiat Res; 2018 Sep; 59(5):604-615. PubMed ID: 30085197
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of involved-field conformal radiotherapy for cervical and upper-thoracic esophageal cancer.
Ma JB; Song YP; Yu JM; Zhou W; Cheng EC; Zhang XQ; Kong L
Onkologie; 2011; 34(11):599-604. PubMed ID: 22104156
[TBL] [Abstract][Full Text] [Related]
12. Patterns of failure and clinical outcomes of definitive radiotherapy for cervical esophageal cancer.
Zhao L; Zhou Y; Mu Y; Chai G; Xiao F; Tan L; Lin SH; Shi M
Oncotarget; 2017 Mar; 8(13):21852-21860. PubMed ID: 28423530
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the value of ENI in radiotherapy for cervical and upper thoracic esophageal cancer: a retrospective analysis.
Liu M; Zhao K; Chen Y; Jiang GL
Radiat Oncol; 2014 Oct; 9():232. PubMed ID: 25344056
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiotherapy for cervical esophageal squamous cell carcinoma without hypopharyngeal invasion: dose distribution and clinical outcome.
Ishida Y; Sakanaka K; Fujii K; Itasaka S; Mizowaki T
J Radiat Res; 2019 Jul; 60(4):517-526. PubMed ID: 31083715
[TBL] [Abstract][Full Text] [Related]
15. Lymph node metastasis in sinonasal squamous cell carcinoma treated with IMRT/3D-CRT.
Guan X; Wang X; Liu Y; Hu C; Zhu G
Oral Oncol; 2013 Jan; 49(1):60-5. PubMed ID: 22884302
[TBL] [Abstract][Full Text] [Related]
16. Elective lymph node irradiation late course accelerated hyper-fractionated radiotherapy plus concurrent cisplatin-based chemotherapy for esophageal squamous cell carcinoma: a phase II study.
Wang D; Yang J; Zhu J; Li B; Zhai L; Sun M; Gong H; Zhou T; Wei Y; Huang W; Wang Z; Li H; Zhang Z
Radiat Oncol; 2013 May; 8():108. PubMed ID: 23638721
[TBL] [Abstract][Full Text] [Related]
17. Concurrent chemoradiotherapy with elective lymph node irradiation for esophageal cancer: a systemic review and pooled analysis of the literature.
Du D; Song T; Liang X; Fang M; Wu S
Dis Esophagus; 2017 Feb; 30(2):1-9. PubMed ID: 26918886
[TBL] [Abstract][Full Text] [Related]
18. Target volume delineation for radical radiotherapy of early oesophageal carcinoma in elderly patients.
Su J; Zhu S; Liu Z; Zhao Y; Song C
Cancer Radiother; 2017 Feb; 21(1):34-39. PubMed ID: 28041813
[TBL] [Abstract][Full Text] [Related]
19. Details of recurrence sites after elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) combined with chemotherapy for thoracic esophageal squamous cell carcinoma--a retrospective analysis.
Yamashita H; Okuma K; Wakui R; Kobayashi-Shibata S; Ohtomo K; Nakagawa K
Radiother Oncol; 2011 Feb; 98(2):255-60. PubMed ID: 21074880
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of concurrent chemoradiotherapy with elective nodal irradiation for inoperable esophageal cancer.
Jing Z; Chen T; Zhang X; Wu S
Cancer Sci; 2017 Sep; 108(9):1828-1833. PubMed ID: 28665042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
